The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim analysis of a randomized, open-label phase 2 study of talimogene laherparepvec (T-VEC) neoadjuvant treatment (neotx) plus surgery (surgx) vs surgx for resectable stage IIIB-IVM1a melanoma (MEL).
 
Robert Hans Ingemar Andtbacka
Honoraria - Aduro Biotech; Amgen; Merck/Schering Plough; Novartis
Consulting or Advisory Role - Aduro Biotech; Amgen; Merck/Schering Plough; Novartis
Research Funding - Amgen (Inst); Idera (Inst); Oncolys BioPharma (Inst); OncoSec (Inst); Provectus (Inst); Takara Bio (Inst); Viralytics (Inst); X4 Pharma (Inst)
 
Reinhard Dummer
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sun Pharma; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sun Pharma; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
 
David E. Gyorki
Honoraria - Amgen
Travel, Accommodations, Expenses - Amgen
 
Adam C. Berger
Honoraria - Castle Biosciences; Genomic Health
Consulting or Advisory Role - Castle Biosciences
Speakers' Bureau - Cardinal Health
Research Funding - Castle Biosciences
 
Robert Martin Conry
Speakers' Bureau - Bristol-Myers Squibb; Merck; Novartis
 
Lev V. Demidov
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
 
Edward Chan
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Sheryl Treichel
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Mark B. Faries
Consulting or Advisory Role - Immune Design
Speakers' Bureau - Castle Biosciences; Delcath Systems; Novartis
 
Merrick I. Ross
Honoraria - Amgen; Merck
Consulting or Advisory Role - Amgen; Merck
Speakers' Bureau - Amgen
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Amgen; Merck